Skip to main content
Premium Trial:

Request an Annual Quote

Arrayit, DHK Enter Distribution Deal for Genomic Testing in India

NEW YORK (GenomeWeb News) – DHK Medical Products will distribute Arrayit's microarray-based genomic tests in India as part of a three-year deal announced today.

Under the terms of the agreement, DHK will offer Arrayit's tests through a planned expanding of a national network of 800 American Medical Center facilities. Arrayit, based in Sunnyvale, Calif., will offer its Variation Identification Platform microarray technology and blood card collection procedure to provide to patients in India information about their genetic predisposition to ailments such as hypertension, obesity, diabetes, cardiovascular disease, breast and ovarian cancer, and Parkinson's disease.

The technology identifies SNP variants in a patient's DNA. Results will be communicated to patients by DHK doctors, and DHK will provide on-site counseling and treatment options as necessary, the partners said.

Chandigarh, India-based DHK estimated that it will sell 25,000 genomic tests in the first year of the deal, 50,000 in the second, and 100,000 in the third year. Cumulative revenues to Arrayit stemming from the agreement are estimated at $16.8 million.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.